PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival

PIK3CA mutations are believed to contribute to the pathogenesis of human papillomavirus (HPV)-associated head and neck squamous cell carcinomas (HNSCC). This study aims to establish the frequency of PIK3CA mutations in a Portuguese HNSCC cohort and to determine their association with the HPV status...

Full description

Bibliographic Details
Main Authors: Daniela Cochicho, Susana Esteves, Miguel Rito, Fernanda Silva, Luís Martins, Pedro Montalvão, Mário Cunha, Miguel Magalhães, Rui M. Gil da Costa, Ana Felix
Format: Article
Language:English
Published: MDPI AG 2022-03-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/5/1286
_version_ 1797475493065261056
author Daniela Cochicho
Susana Esteves
Miguel Rito
Fernanda Silva
Luís Martins
Pedro Montalvão
Mário Cunha
Miguel Magalhães
Rui M. Gil da Costa
Ana Felix
author_facet Daniela Cochicho
Susana Esteves
Miguel Rito
Fernanda Silva
Luís Martins
Pedro Montalvão
Mário Cunha
Miguel Magalhães
Rui M. Gil da Costa
Ana Felix
author_sort Daniela Cochicho
collection DOAJ
description PIK3CA mutations are believed to contribute to the pathogenesis of human papillomavirus (HPV)-associated head and neck squamous cell carcinomas (HNSCC). This study aims to establish the frequency of PIK3CA mutations in a Portuguese HNSCC cohort and to determine their association with the HPV status and patient survival. A meta-analysis of scientific literature also revealed widely different mutation rates in cohorts from different world regions and a trend towards improved prognosis among patients with PIK3CA mutations. DNA samples were available from 95 patients diagnosed with HNSCC at the Portuguese Institute of Oncology in Lisbon between 2010 and 2019. HPV status was established based on viral DNA detected using real-time PCR. The evaluation of PIK3CA gene mutations was performed by real-time PCR for four mutations (H1047L; E542K, E545K, and E545D). Thirty-seven cases were found to harbour PIK3CA mutations (39%), with the E545D mutation (73%) more frequently detected. There were no significant associations between the mutational status and HPV status (74% WT and 68% MUT were HPV (+); <i>p</i> = 0.489) or overall survival (OS) (3-year OS: WT 54% and MUT 65%; <i>p</i> = 0.090). HPV status was the only factor significantly associated with both OS and disease-free survival (DFS), with HPV (+) patients having consistently better outcomes (3-year OS: HPV (+) 65% and HPV (−) 36%; <i>p</i> = 0.007; DFS HPV (+) 83% and HPV (−) 43%; <i>p</i> = 0.001). There was a statistically significant interaction effect between HPV status and PIK3CA mutation regarding DFS (Interaction test: <i>p</i> = 0.026). In HPV (+) patients, PIK3CA wild-type is associated with a significant 4.64 times increase in the hazard of recurrence or death (HR = 4.64; 95% CI 1.02–20.99; <i>p</i> = 0.047). Overall, PIK3CA gene mutations are present in a large number of patients and may help define patient subsets who can benefit from therapies targeting the PI3K pathway. The systematic assessment of PIK3CA gene mutations in HNSCC patients will require further methodological standardisation.
first_indexed 2024-03-09T20:44:55Z
format Article
id doaj.art-9dbe6b78e9ae4feea4819f99e66c1cc5
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T20:44:55Z
publishDate 2022-03-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-9dbe6b78e9ae4feea4819f99e66c1cc52023-11-23T22:48:43ZengMDPI AGCancers2072-66942022-03-01145128610.3390/cancers14051286PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient SurvivalDaniela Cochicho0Susana Esteves1Miguel Rito2Fernanda Silva3Luís Martins4Pedro Montalvão5Mário Cunha6Miguel Magalhães7Rui M. Gil da Costa8Ana Felix9NOVA Medical School, NOVA University of Lisbon, 1099-085 Lisbon, PortugalClinical Research Unit, IPOLFG, 1099-023 Lisbon, PortugalPathology Department, IPOLFG, 1099-023 Lisbon, PortugalNOVA Medical School, NOVA University of Lisbon, 1099-085 Lisbon, PortugalVirology Laboratory from Clinical Pathology Department, IPOLFG, 1099-023 Lisbon, PortugalOtorhinolaryngology Department, IPOLFG, 1099-023 Lisbon, PortugalVirology Laboratory from Clinical Pathology Department, IPOLFG, 1099-023 Lisbon, PortugalOtorhinolaryngology Department, IPOLFG, 1099-023 Lisbon, PortugalPost-Graduate Programme in Adult Health (PPGSAD), Morphology Department, University Hospital (HUUFMA), Federal University of Maranhão, São Luís 65080-805, BrazilNOVA Medical School, NOVA University of Lisbon, 1099-085 Lisbon, PortugalPIK3CA mutations are believed to contribute to the pathogenesis of human papillomavirus (HPV)-associated head and neck squamous cell carcinomas (HNSCC). This study aims to establish the frequency of PIK3CA mutations in a Portuguese HNSCC cohort and to determine their association with the HPV status and patient survival. A meta-analysis of scientific literature also revealed widely different mutation rates in cohorts from different world regions and a trend towards improved prognosis among patients with PIK3CA mutations. DNA samples were available from 95 patients diagnosed with HNSCC at the Portuguese Institute of Oncology in Lisbon between 2010 and 2019. HPV status was established based on viral DNA detected using real-time PCR. The evaluation of PIK3CA gene mutations was performed by real-time PCR for four mutations (H1047L; E542K, E545K, and E545D). Thirty-seven cases were found to harbour PIK3CA mutations (39%), with the E545D mutation (73%) more frequently detected. There were no significant associations between the mutational status and HPV status (74% WT and 68% MUT were HPV (+); <i>p</i> = 0.489) or overall survival (OS) (3-year OS: WT 54% and MUT 65%; <i>p</i> = 0.090). HPV status was the only factor significantly associated with both OS and disease-free survival (DFS), with HPV (+) patients having consistently better outcomes (3-year OS: HPV (+) 65% and HPV (−) 36%; <i>p</i> = 0.007; DFS HPV (+) 83% and HPV (−) 43%; <i>p</i> = 0.001). There was a statistically significant interaction effect between HPV status and PIK3CA mutation regarding DFS (Interaction test: <i>p</i> = 0.026). In HPV (+) patients, PIK3CA wild-type is associated with a significant 4.64 times increase in the hazard of recurrence or death (HR = 4.64; 95% CI 1.02–20.99; <i>p</i> = 0.047). Overall, PIK3CA gene mutations are present in a large number of patients and may help define patient subsets who can benefit from therapies targeting the PI3K pathway. The systematic assessment of PIK3CA gene mutations in HNSCC patients will require further methodological standardisation.https://www.mdpi.com/2072-6694/14/5/1286HNSCCHPVp16 INK4aPIK3CA
spellingShingle Daniela Cochicho
Susana Esteves
Miguel Rito
Fernanda Silva
Luís Martins
Pedro Montalvão
Mário Cunha
Miguel Magalhães
Rui M. Gil da Costa
Ana Felix
PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival
Cancers
HNSCC
HPV
p16 INK4a
PIK3CA
title PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival
title_full PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival
title_fullStr PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival
title_full_unstemmed PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival
title_short PIK3CA Gene Mutations in HNSCC: Systematic Review and Correlations with HPV Status and Patient Survival
title_sort pik3ca gene mutations in hnscc systematic review and correlations with hpv status and patient survival
topic HNSCC
HPV
p16 INK4a
PIK3CA
url https://www.mdpi.com/2072-6694/14/5/1286
work_keys_str_mv AT danielacochicho pik3cagenemutationsinhnsccsystematicreviewandcorrelationswithhpvstatusandpatientsurvival
AT susanaesteves pik3cagenemutationsinhnsccsystematicreviewandcorrelationswithhpvstatusandpatientsurvival
AT miguelrito pik3cagenemutationsinhnsccsystematicreviewandcorrelationswithhpvstatusandpatientsurvival
AT fernandasilva pik3cagenemutationsinhnsccsystematicreviewandcorrelationswithhpvstatusandpatientsurvival
AT luismartins pik3cagenemutationsinhnsccsystematicreviewandcorrelationswithhpvstatusandpatientsurvival
AT pedromontalvao pik3cagenemutationsinhnsccsystematicreviewandcorrelationswithhpvstatusandpatientsurvival
AT mariocunha pik3cagenemutationsinhnsccsystematicreviewandcorrelationswithhpvstatusandpatientsurvival
AT miguelmagalhaes pik3cagenemutationsinhnsccsystematicreviewandcorrelationswithhpvstatusandpatientsurvival
AT ruimgildacosta pik3cagenemutationsinhnsccsystematicreviewandcorrelationswithhpvstatusandpatientsurvival
AT anafelix pik3cagenemutationsinhnsccsystematicreviewandcorrelationswithhpvstatusandpatientsurvival